215 related articles for article (PubMed ID: 23568010)
21. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.
Wang Q; Huang Z; Ni S; Xiao X; Xu Q; Wang L; Huang D; Tan C; Sheng W; Du X
PLoS One; 2012; 7(9):e44398. PubMed ID: 22970209
[TBL] [Abstract][Full Text] [Related]
22. Fecal miR-29a and miR-224 as the noninvasive biomarkers for colorectal cancer.
Zhu Y; Xu A; Li J; Fu J; Wang G; Yang Y; Cui L; Sun J
Cancer Biomark; 2016; 16(2):259-64. PubMed ID: 26756616
[TBL] [Abstract][Full Text] [Related]
23. Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.
Ng L; Wan TM; Man JH; Chow AK; Iyer D; Chen G; Yau TC; Lo OS; Foo DC; Poon JT; Leung WK; Pang RW; Law WL
Oncotarget; 2017 Apr; 8(16):27393-27400. PubMed ID: 28404964
[TBL] [Abstract][Full Text] [Related]
24. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
[TBL] [Abstract][Full Text] [Related]
25. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
Luo X; Wu Y; Ji M; Zhang S
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
[TBL] [Abstract][Full Text] [Related]
26. Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer.
Liu GH; Zhou ZG; Chen R; Wang MJ; Zhou B; Li Y; Sun XF
Tumour Biol; 2013 Aug; 34(4):2175-81. PubMed ID: 23625654
[TBL] [Abstract][Full Text] [Related]
27. Identification of a circulating microRNA signature for colorectal cancer detection.
Wang J; Huang SK; Zhao M; Yang M; Zhong JL; Gu YY; Peng H; Che YQ; Huang CZ
PLoS One; 2014; 9(4):e87451. PubMed ID: 24709885
[TBL] [Abstract][Full Text] [Related]
28. Plasma miR-21: a potential diagnostic marker of colorectal cancer.
Kanaan Z; Rai SN; Eichenberger MR; Roberts H; Keskey B; Pan J; Galandiuk S
Ann Surg; 2012 Sep; 256(3):544-51. PubMed ID: 22868372
[TBL] [Abstract][Full Text] [Related]
29. Circulating serum exosomal
Lu X; Lu J; Wang S; Zhang Y; Ding Y; Shen X; Jing R; Ju S; Chen H; Cong H
Future Oncol; 2021 Mar; 17(8):907-919. PubMed ID: 33533649
[TBL] [Abstract][Full Text] [Related]
30. Expression of specific microRNAs in tissue and plasma in colorectal cancer.
Fellizar A; Refuerzo V; Ramos JD; Albano PM
J Pathol Transl Med; 2023 May; 57(3):147-157. PubMed ID: 35501673
[TBL] [Abstract][Full Text] [Related]
31. Identification of a four-microRNA panel in serum as promising biomarker for colorectal carcinoma detection.
Huang G; Wei B; Chen Z; Wang J; Zhao L; Peng X; Liu K; Lai Y; Ni L
Biomark Med; 2020 Jun; 14(9):749-760. PubMed ID: 32672054
[No Abstract] [Full Text] [Related]
32. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
[TBL] [Abstract][Full Text] [Related]
33. Detection of miR-1246, miR-23a and miR-451 in sera of colorectal carcinoma patients: a case-control study in Cairo University hospital.
Salah M; Shaheen I; El-Shanawany P; Saad NE; Saad R; El Guibaly M; Momen N
Afr Health Sci; 2020 Sep; 20(3):1283-1291. PubMed ID: 33402976
[TBL] [Abstract][Full Text] [Related]
34. Technical factors involved in the measurement of circulating microRNA biomarkers for the detection of colorectal neoplasia.
Yamada A; Cox MA; Gaffney KA; Moreland A; Boland CR; Goel A
PLoS One; 2014; 9(11):e112481. PubMed ID: 25405754
[TBL] [Abstract][Full Text] [Related]
35. Clinical Potentials of miR-576-3p, miR-613, NDRG2 and YKL40 in Colorectal Cancer Patients.
Eldaly MN; Metwally FM; Shousha WG; El-Saiid AS; Ramadan SS
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1689-1695. PubMed ID: 32592365
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of microRNA 92a Expression and Its Target Protein Bim in Colorectal Cancer.
Zaki A; Fawzy A; Akel SY; Gamal H; Elshimy RAA
Asian Pac J Cancer Prev; 2022 Feb; 23(2):723-730. PubMed ID: 35225486
[TBL] [Abstract][Full Text] [Related]
37. Serum exosomal miR-377-3p and miR-381-3p as diagnostic biomarkers in colorectal cancer.
Wang L; Song X; Yu M; Niu L; Zhao Y; Tang Y; Zheng B; Song X; Xie L
Future Oncol; 2022 Mar; 18(7):793-805. PubMed ID: 34854318
[No Abstract] [Full Text] [Related]
38. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
[TBL] [Abstract][Full Text] [Related]
39. Serum microRNA signatures and metabolomics have high diagnostic value in colorectal cancer using two novel methods.
Liu HN; Liu TT; Wu H; Chen YJ; Tseng YJ; Yao C; Weng SQ; Dong L; Shen XZ
Cancer Sci; 2018 Apr; 109(4):1185-1194. PubMed ID: 29363233
[TBL] [Abstract][Full Text] [Related]
40. Serum micro-RNA Identifies Early Stage Colorectal Cancer in a Multi-Ethnic Population.
Shiosaki J; Tiirikainen M; Peplowska K; Shaeffer D; Machida M; Sakamoto K; Takahashi M; Kojima K; Machi J; Bryant-Greenwood P; Kuwada SK
Asian Pac J Cancer Prev; 2020 Oct; 21(10):3019-3026. PubMed ID: 33112562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
